 WOODSTOCK, Ga.--BUSINESS WIRE--Sonoma Pharmaceuticals, Inc. Nasdaq: SNOA, a global healthcare leader developing and producing stabilized hypochlorous acid HOCl products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions, today announced that it will be featured as a presenting company at the H.C. Wainwright BioConnect Conference. The conference is being held on January 10-13, 2022 virtually. Amy Trombly, CEO and Jerry Dvon 